Appreciate the views.
What would you consider as the key risks?
Competition?
If the US requires significant marketing to get traction, do they have enough funding with the last CR to keep momentum up?
- Forums
- ASX - By Stock
- EYE
- What makes iTrack Advance so special?
EYE
nova eye medical limited
Add to My Watchlist
4.17%
!
12.5¢

What makes iTrack Advance so special?, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.5¢ |
Change
0.005(4.17%) |
Mkt cap ! $35.51M |
Open | High | Low | Value | Volume |
12.0¢ | 12.5¢ | 12.0¢ | $70.91K | 584.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 268742 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 22056 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 268742 | 0.120 |
6 | 427932 | 0.115 |
5 | 671828 | 0.110 |
6 | 223371 | 0.105 |
6 | 295150 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 18584 | 1 |
0.130 | 104745 | 2 |
0.135 | 366584 | 3 |
0.140 | 346515 | 3 |
0.150 | 6000 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online